Breaking News Instant updates and real-time market news.

2022-06-17 05:47:31 KR Kroger $49.84 / -1 (-1.97%) 05:47 06/17/22 06/17 05:47 06/17/22 05:47	Citi 'incrementally cautious' on Kroger after Q1 call Citi analyst Paul Lejuez came away from Kroger's Q1 earnings call "incrementally cautious on an otherwise in-line quarter." Average basket size was up, driven by retail price increases, but units were down, while traffic was up slightly, Lejuez tells investors in a research note. With cost pressures continuing, Kroger may feel pressure to invest in price to recapture market share, which would drive gross margin erosion, says the analyst. He keeps a Sell rating on the shares with a $45 price target.	23 Jun 19 Sep

2022-06-17 05:47:31

Kroger

$49.84 / -1 (-1.97%)

05:47

06/17/22

06/17

05:47

06/17/22

05:47

Citi 'incrementally cautious' on Kroger after Q1 call

Citi analyst Paul Lejuez came away from Kroger's Q1 earnings call "incrementally cautious on an otherwise in-line quarter." Average basket size was up, driven by retail price increases, but units were down, while traffic was up slightly, Lejuez tells investors in a research note. With cost pressures continuing, Kroger may feel pressure to invest in price to recapture market share, which would drive gross margin erosion, says the analyst. He keeps a Sell rating on the shares with a $45 price target.

23
Jun
19
Sep

OTHER BREAKING NEWS FROM THE FLY

Recommendations	Equitable Group price target lowered to C$79 from C$80 at Scotiabank » 11:27 08/11/22 08/11 11:27 08/11/22 11:27 EQGPF Equitable Group $43.38 / -1.235 (-2.77%) Scotiabank analyst Meny… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research EQGPF Equitable Group $43.38 / -1.235 (-2.77%) 08/10/22 RBC Capital Equitable Group price target lowered to C$74 from C$75 at RBC Capital 08/10/22 National Bank Equitable Group price target lowered to C$73 from C$75 at National Bank 07/27/22 National Bank Equitable Group price target lowered to C$75 from C$86 at National Bank 05/12/22 BMO Capital Equitable Group price target lowered to C$91 from C$97 at BMO Capital
Recommendations	Dexterra Group price target lowered to C$8 from C$10 at Scotiabank » 11:27 08/11/22 08/11 11:27 08/11/22 11:27 HZNOF Dexterra Group $4.63 / + (+0.00%) Scotiabank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research HZNOF Dexterra Group $4.63 / + (+0.00%) 11:21 Today National Bank Dexterra Group price target lowered to C$10.50 from C$12 at National Bank 07/05/22 Raymond James Dexterra Group downgraded to Market Perform from Outperform at Raymond James 05/12/22 Scotiabank Dexterra Group price target lowered to C$10 from C$11 at Scotiabank 05/12/22 Raymond James Dexterra downgraded to Outperform from Strong Buy at Raymond James
Recommendations	CAE price target lowered to C$37.50 from C$43.50 at Scotiabank » 11:26 08/11/22 08/11 11:26 08/11/22 11:26 CAE CAE $20.75 / -0.7 (-3.26%) Scotiabank analyst Konark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CAE CAE $20.75 / -0.7 (-3.26%) 08/10/22 CAE falls -14.0% 08/10/22 CAE falls -12.1% 08/10/22 CAE lowers FY23 consolidated adjusted segment operating income growth view 07/19/22 CAE launches electric aircraft modification program with Piper Aircraft CAE CAE $20.75 / -0.7 (-3.26%) 06/23/22 RBC Capital CAE assumed with an Outperform at RBC Capital 06/08/22 BMO Capital CAE price target lowered to C$42 from C$45 at BMO Capital 06/08/22 Scotiabank CAE price target raised to C$43.50 from C$43 at Scotiabank 06/06/22 BofA CAE upgraded to Neutral from Underperform at BofA CAE CAE $20.75 / -0.7 (-3.26%) 08/10/22 CAE reports Q1 adjusted EPS C$0.06 vs. C$0.19 a year ago 05/31/22 CAE sees FY23 Capital Expenditures $250M 05/31/22 CAE reports Q4 adjustedd EPS 29c, consensus 18c
Recommendations	Boyd Group Services price target raised to C$215 from C$200 at Scotiabank » 11:26 08/11/22 08/11 11:26 08/11/22 11:26 BYDGF Boyd Group Services $150.11 / +26.94 (+21.87%) Scotiabank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BYDGF Boyd Group Services $150.11 / +26.94 (+21.87%) 07:24 Today National Bank Boyd Group Services downgraded to Sector Perform from Outperform at National Bank 07:02 Today Stifel Boyd Group Services upgraded to Buy from Hold at Stifel 07/25/22 RBC Capital Boyd Group Services assumed with an Outperform at RBC Capital 07/22/22 CIBC Boyd Group Services price target lowered to C$175 from C$180 at CIBC
Recommendations	Argonaut Gold price target lowered to C$1.15 from C$1.25 at Scotiabank » 11:25 08/11/22 08/11 11:25 08/11/22 11:25 ARNGF Argonaut Gold / + Scotiabank analyst Ovais… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ARNGF Argonaut Gold / + 08/02/22 Stifel Argonaut Gold price target lowered to C$1.50 from C$3.50 at Stifel 07/07/22 Desjardins Argonaut Gold price target lowered to C$1.25 from C$2.50 at Desjardins 07/07/22 BMO Capital Argonaut Gold resumed with an Outperform rating at BMO Capital 07/06/22 Scotiabank Argonaut Gold price target lowered to C$1.25 from C$3.00 at Scotiabank
Recommendations	Andlauer Healthcare price target raised to C$57 from C$54 at Scotiabank » 11:25 08/11/22 08/11 11:25 08/11/22 11:25 ANDHF Andlauer Healthcare $37.80 / + (+0.00%) Scotiabank analyst Konark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ANDHF Andlauer Healthcare $37.80 / + (+0.00%) 07/12/22 National Bank Andlauer Healthcare upgraded to Outperform from Sector Perform at National Bank 05/06/22 RBC Capital Andlauer Healthcare price target lowered to C$48 from C$52 at RBC Capital 05/06/22 National Bank Andlauer Healthcare price target raised to C$50 from C$49.50 at National Bank 05/06/22 TD Securities Andlauer Healthcare price target lowered to C$54 from C$56 at TD Securities
Options	Lemonade call volume above normal and directionally bullish » 11:25 08/11/22 08/11 11:25 08/11/22 11:25 LMND Lemonade $31.14 / +2.5 (+8.73%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options LMND Lemonade $31.14 / +2.5 (+8.73%) 08/08/22 Lemonade jumps 11% to nearly $28 after Q2 report 08/08/22 Lemonade jumps 11% to nearly $28 after Q2 report 08/01/22 Lemonade sells Metromile's Enterprise Business Solutions platform to EIS 05/10/22 Lemonade trading resumes LMND Lemonade $31.14 / +2.5 (+8.73%) 08/10/22 Oppenheimer Lemonade price target raised to $35 from $30 at Oppenheimer 08/10/22 Barclays Lemonade price target raised to $28 from $20 at Barclays 07/18/22 Piper Sandler Lemonade downgraded to Neutral from Overweight at Piper Sandler 05/11/22 Oppenheimer Lemonade price target lowered to $30 from $45 at Oppenheimer LMND Lemonade $31.14 / +2.5 (+8.73%) 08/08/22 Lemonade raises FY22 revenue view to $236M-$239M, consensus $213.41M 08/08/22 Lemonade sees Q3 revenue $63M-$65M, consensus $56.97M 08/08/22 Lemonade reports Q2 EPS ($1.10), consensus ($1.32) 05/09/22 Lemonade sees FY22 revenue $205M-$208M, consensus $216.49M LMND Lemonade $31.14 / +2.5 (+8.73%) 02/14/22 Socially conscious sock maker Bombas exploring IPO, Bloomberg says LMND Lemonade $31.14 / +2.5 (+8.73%) 08/08/22 Fly Intel: After-Hours Movers 08/07/22 Short Report: Bed Bath Beyond in short-squeeze spotlight 06/25/22 Short Report: Bears undeterred by bounce in growth names 02/23/22 Fly Intel: After-Hours Movers LMND Lemonade $31.14 / +2.5 (+8.73%) 08/10/22 Lemonade call volume above normal and directionally bullish 08/08/22 Lemonade options imply 12.1% move in share price post-earnings 07/06/22 Largest borrow rate increases among liquid names 06/14/22 Largest borrow rate increases among liquid names
Recommendations	American Hotel Income Properties price target lowered to C$4.50 at Scotiabank » 11:24 08/11/22 08/11 11:24 08/11/22 11:24 AHOTF American Hotel Income Properties $2.85 / +0.1745 (+6.53%) Scotiabank analyst Mario… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research AHOTF American Hotel Income Properties $2.85 / +0.1745 (+6.53%) 11:20 Today National Bank American Hotel Income Properties price target raised to C$4 at National Bank 05/18/22 National Bank American Hotel Income Properties price target lowered to C$4.75 at National Bank 05/12/22 Scotiabank American Hotel Income price target lowered to C$4.75 from C$5 at Scotiabank 03/10/22 National Bank American Hotel Income Properties price target raised to C$5 at National Bank
Recommendations	ATS Automation price target raised to C$60 from C$55 at Scotiabank » 11:24 08/11/22 08/11 11:24 08/11/22 11:24 ATSAF ATS Automation $35.63 / +2.6651 (+8.08%) Scotiabank analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ATSAF ATS Automation $35.63 / +2.6651 (+8.08%) 05/20/22 Scotiabank ATS Automation price target raised to C$55 from C$53 at Scotiabank 05/20/22 TD Securities ATS Automation price target raised to C$52 from C$51 at TD Securities 05/20/22 National Bank ATS Automation price target lowered to C$52 from C$66 at National Bank 05/18/22 Scotiabank ATS Automation price target lowered to C$53 from C$63 at Scotiabank
Recommendations	Peyto Exploration price target lowered to C$19 from C$19.50 at National Bank » 11:22 08/11/22 08/11 11:22 08/11/22 11:22 PEYUF Peyto Exploration $10.80 / +0.32 (+3.05%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PEYUF Peyto Exploration $10.80 / +0.32 (+3.05%) 07/18/22 National Bank Peyto Exploration price target lowered to C$19.50 from C$23 at National Bank 07/14/22 Scotiabank Peyto Exploration price target raised to C$24 from C$23 at Scotiabank 06/30/22 Stifel Peyto Exploration price target lowered to C$19.25 from C$20 at Stifel 06/16/22 National Bank Peyto Exploration price target raised to C$23 from C$18 at National Bank

Recommendations	Goeasy price target raised to C$170 from C$155 at National Bank » 11:22 08/11/22 08/11 11:22 08/11/22 11:22 EHMEF Goeasy $101.67 / +5.36 (+5.57%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research EHMEF Goeasy $101.67 / +5.36 (+5.57%) 07/19/22 Goeasy appoints Jonathan Tetrault to board of directors 07/05/22 Goeasy announces $500M increase to securitization facility EHMEF Goeasy $101.67 / +5.36 (+5.57%) 08/04/22 TD Securities Goeasy price target lowered to C$195 from C$215 at TD Securities 07/20/22 Scotiabank Goeasy price target lowered to C$140 from C$160 at Scotiabank 07/08/22 Raymond James Goeasy price target lowered to C$202 from C$213 at Raymond James 05/13/22 BMO Capital Goeasy price target lowered to C$225 from C$228 at BMO Capital
Recommendations	Dexterra Group price target lowered to C$10.50 from C$12 at National Bank » 11:21 08/11/22 08/11 11:21 08/11/22 11:21 HZNOF Dexterra Group $4.63 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research HZNOF Dexterra Group $4.63 / + (+0.00%) 07/05/22 Raymond James Dexterra Group downgraded to Market Perform from Outperform at Raymond James 05/12/22 Scotiabank Dexterra Group price target lowered to C$10 from C$11 at Scotiabank 05/12/22 Raymond James Dexterra downgraded to Outperform from Strong Buy at Raymond James 05/11/22 TD Securities Dexterra Group price target lowered to C$9 from C$11.50 at TD Securities
Conference/Events	Jefferies consumer goods analyst to hold analyst/industry conference call » 11:20 08/11/22 08/11 11:20 08/11/22 11:20 Retail & Consumer… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Recommendations	American Hotel Income Properties price target raised to C$4 at National Bank » 11:20 08/11/22 08/11 11:20 08/11/22 11:20 AHOTF American Hotel Income Properties $2.85 / +0.1745 (+6.53%) National Bank analyst Tal… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research AHOTF American Hotel Income Properties $2.85 / +0.1745 (+6.53%) 05/18/22 National Bank American Hotel Income Properties price target lowered to C$4.75 at National Bank 05/12/22 Scotiabank American Hotel Income price target lowered to C$4.75 from C$5 at Scotiabank 03/10/22 National Bank American Hotel Income Properties price target raised to C$5 at National Bank 11/29/21 BMO Capital American Hotel Income Properties price target raised to C$4.50 at BMO Capital
Recommendations	Dutch Bros price target raised to $45 from $30 at Stifel » 11:17 08/11/22 08/11 11:17 08/11/22 11:17 BROS Dutch Bros $51.52 / +7.46 (+16.93%) Stifel analyst Chris… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options BROS Dutch Bros $51.52 / +7.46 (+16.93%) 09:47 Today Dutch Bros rises 17.9% 06/15/22 Dutch Bros CEO: Demand is not where we would like it to be 05/12/22 Dutch Bros falls -28.4% 05/12/22 Dutch Bros falls -40.1% BROS Dutch Bros $51.52 / +7.46 (+16.93%) 06:31 Today Baird Dutch Bros price target raised to $46 from $30 at Baird 06:14 Today Piper Sandler Dutch Bros price target raised to $50 from $44 at Piper Sandler 07/11/22 Baird Dutch Bros downgraded to Neutral from Outperform at Baird 06/09/22 Barclays Dutch Bros price target raised to $34 from $25 at Barclays BROS Dutch Bros $51.52 / +7.46 (+16.93%) 08/10/22 Dutch Bros backs FY22 revenue view at least $715M, consensus $713.11M 08/10/22 Dutch Bros reports Q2 adjusted EPS 5c, consensus 7c 05/11/22 Dutch Bros sees FY22 revenue $700M-$715M, consensus $717.22M 05/11/22 Dutch Bros reports Q1 adjusted EPS (2c), consensus 1c 11 Mar 15 Sep BROS Dutch Bros $51.52 / +7.46 (+16.93%) 08/10/22 Fly Intel: After-Hours Movers 06/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/21/22 Short Report: Bearish bets increase in meme names GameStop and Carvana 05/12/22 What You Missed On Wall Street This Morning BROS Dutch Bros $51.52 / +7.46 (+16.93%) 08/10/22 Dutch Bros options imply 13.3% move in share price post-earnings 08/09/22 Dutch Bros put volume heavy and directionally bearish 07/29/22 Largest borrow rate increases among liquid names 07/11/22 Largest borrow rate increases among liquid names
Technical Analysis	NASDAQ market internals summary » 11:17 08/11/22 08/11 11:17 08/11/22 11:17 $NSD NASDAQ Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 10:17 Today NASDAQ market internals summary 08/10/22 NASDAQ market internals summary 08/10/22 NASDAQ market internals summary 08/10/22 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 11:16 08/11/22 08/11 11:16 08/11/22 11:16 $NYE NYSE Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 10:16 Today NYSE market internals summary 08/10/22 NYSE market internals summary 08/10/22 NYSE market internals summary 08/10/22 NYSE market internals summary
Recommendations	Crew Energy price target raised to C$8 from C$7.75 at Desjardins » 11:16 08/11/22 08/11 11:16 08/11/22 11:16 CWEGF Crew Energy $4.47 / +0.17301 (+4.02%) Desjardins analyst Chris… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research CWEGF Crew Energy $4.47 / +0.17301 (+4.02%) 04/21/22 Crew Energy reports Q1 average production 33,300 boe per day CWEGF Crew Energy $4.47 / +0.17301 (+4.02%) 08/10/22 Stifel Crew Energy price target raised to C$8 from C$7.50 at Stifel 08/10/22 Raymond James Crew Energy price target raised to C$8 from C$7.50 at Raymond James 08/09/22 Scotiabank Crew Energy price target raised to C$8 from C$7.50 at Scotiabank 07/18/22 National Bank Crew Energy price target lowered to C$6.75 from C$7.50 at National Bank
Conference/Events	UBS semiconductor analysts hold an investor relations call series » 11:15 08/11/22 08/11 11:15 08/11/22 11:15 MCHP Microchip $71.68 / +1.05 (+1.49%) Semiconductors Analysts… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MCHP Microchip $71.68 / +1.05 (+1.49%) 08/04/22 Microchip announces SAM9X60DIG-SOM ARM926EJ-S-based embedded MPU 08/02/22 Microchip increased quarterly dividend 9.1% 08/02/22 Microchip announces SMC 2000 series of CXL based Smart Memory Controllers 06/30/22 Microchip announces maXTounch Knob on Display controller MCHP Microchip $71.68 / +1.05 (+1.49%) 08/03/22 B. Riley Microchip price target raised to $86 from $78 at B. Riley 08/03/22 Needham Microchip price target raised to $92 from $75 at Needham 08/03/22 Cowen Microchip price target raised to $72 from $60 at Cowen 08/03/22 JPMorgan Microchip risk/reward attractive at current share levels, says JPMorgan MCHP Microchip $71.68 / +1.05 (+1.49%) 08/02/22 Microchip sees Q2 EPS $1.42-$1.46, consensus $1.34 08/02/22 Microchip reports Q1 EPS $1.37, consensus $1.34 08/02/22 Notable companies reporting after market close 05/09/22 Microchip sees Q1 EPS $1.32-$1.36, consensus $1.28 MCHP Microchip $71.68 / +1.05 (+1.49%) 08/10/22 Chip makers now expect demand slowdown beyond PCs, WSJ reports 08/09/22 Biden signs bill giving $52.7B in subsidies to U.S. chipmakers, Reuters says 07/28/22 House passes bill giving $52B to U.S. chipmakers, Bloomberg reports 07/27/22 Senate pushes bipartisan chip bill to House to boost U.S, production, CNN says MCHP Microchip $71.68 / +1.05 (+1.49%) 06/28/22 What You Missed On Wall Street On Tuesday 06/28/22 What You Missed On Wall Street This Morning 06/28/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/28/22 Fly Intel: Pre-market Movers 11:30 Today Semiconductors 08/15/22 Microchip - MCHP 08/23/22 Microchip Technology Incorporated MCHP Microchip $71.68 / +1.05 (+1.49%) 06/29/22 Notable open interest changes for June 29th
Recommendations	Piper has 'strong conviction on pemvidutide,' still bullish on Altimmune » 11:11 08/11/22 08/11 11:11 08/11/22 11:11 ALT Altimmune $13.27 / +0.39 (+3.03%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ALT Altimmune $13.27 / +0.39 (+3.03%) 04/01/22 Altimmune initiates 48-week Phase 2 MOMENTUM trial of pemvidutide ALT Altimmune $13.27 / +0.39 (+3.03%) 08/03/22 Piper Sandler Piper says Altimmune selloff related to Novo continuing Phase 3 SELECT trial 05/17/22 Piper Sandler Altimmune price target lowered to $25 from $34 at Piper Sandler 04/28/22 Piper Sandler Lilly data does not raise bar for Altimmune, says Piper Sandler 04/12/22 B. Riley Altimmune added to '25 Picks for 22' list at B. Riley ALT Altimmune $13.27 / +0.39 (+3.03%) 07:28 Today Altimmune reports Q2 EPS (42c) vs (60c) last year 05/12/22 Altimmune reports Q1 EPS (44c), consensus (58c) 03/15/22 Altimmune reports Q4 EPS (57c), consensus (65c) ALT Altimmune $13.27 / +0.39 (+3.03%) 03/15/22 Fly Intel: Pre-market Movers 08:30 Today Altimmune - ALT

Hot Stocks	BJ's Restaurants enter partnership with DailyPay » 11:09 08/11/22 08/11 11:09 08/11/22 11:09 BJRI BJ's Restaurants $25.72 / +0.345 (+1.36%) BJ's Restaurants… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Options BJRI BJ's Restaurants $25.72 / +0.345 (+1.36%) 07/25/22 Deutsche Bank BJ's Restaurants price target lowered to $28 from $40 at Deutsche Bank 07/22/22 Citi BJ's Restaurants price target raised to $26 from $24 at Citi 07/22/22 Piper Sandler BJ's Restaurants price target lowered to $29 from $38 at Piper Sandler 07/22/22 Barclays BJ's Restaurants price target lowered to $17 from $21 at Barclays BJRI BJ's Restaurants $25.72 / +0.345 (+1.36%) 07/21/22 BJ's Restaurants reports Q2 EPS 1c, consensus 24c 04/21/22 BJ's Restaurants reports Q1 EPS 6c, consensus (26c) 02/17/22 BJ's Restaurants reports Q4 EPS (20c), consensus (2c) BJRI BJ's Restaurants $25.72 / +0.345 (+1.36%) 07/21/22 Fly Intel: After-Hours Movers 04/21/22 Fly Intel: After-Hours Movers 04/12/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations BJRI BJ's Restaurants $25.72 / +0.345 (+1.36%) 04/21/22 BJs options imply 8.3% move in share price post-earnings
Periodicals	Walgreens offering bonuses up to $75,000 to hire pharmacists, WSJ says » 11:08 08/11/22 08/11 11:08 08/11/22 11:08 WBA Walgreens Boots Alliance $40.53 / +0.62 (+1.55%) Walgreens Boots Alliance… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options WBA Walgreens Boots Alliance $40.53 / +0.62 (+1.55%) 07/13/22 Walgreens Boots Alliance raises quarterly dividend 0.5% to 48c per share 06/28/22 NeuroMetrix appoints Fluegel to board of directors 06/28/22 Walgreens Boots Alliance ends strategic review, to keep ownership of Boots unit 06/28/22 Walgreens Boots Alliance to retain ownership of Boots business, ends review WBA Walgreens Boots Alliance $40.53 / +0.62 (+1.55%) 07/11/22 Evercore ISI Evercore cuts AmerisourceBergen to In Line on valuation, Walgreens overhang 07/08/22 JPMorgan Walgreens Boots Alliance price target lowered to $45 from $52 at JPMorgan 07/05/22 Stifel Stifel says 'logical to assume' Walgreens could look at 1Life Healthcare 07/05/22 RBC Capital Walgreens Boots Alliance price target lowered to $42 from $46 at RBC Capital WBA Walgreens Boots Alliance $40.53 / +0.62 (+1.55%) 06/30/22 Walgreens Boots Alliance backs FY22 EPS outlook of low single digit growth 06/30/22 Walgreens Boots Alliance reports Q3 adjusted EPS 96c, consensus 92c 06/29/22 Notable companies reporting before tomorrow's open 06/29/22 Notable companies reporting before tomorrow's open WBA Walgreens Boots Alliance $40.53 / +0.62 (+1.55%) 06/26/22 Reliance in talks to raise up to $8B for Boots, Mint reports 06/24/22 Walgreens settles class-action lawsuit for $105M, Reuters reports 06/22/22 Four banks lined up to fund Apollo-Reliance bid for Boots, Sky News says 05/26/22 Issa, TDR said to consider dropping out of bidding for Boots, Bloomberg reports WBA Walgreens Boots Alliance $40.53 / +0.62 (+1.55%) 06/30/22 What You Missed On Wall Street On Thursday 06/30/22 What You Missed On Wall Street This Morning 06/30/22 Fly Intel: Pre-market Movers 06/28/22 What You Missed On Wall Street On Tuesday 09/19/22 Groceryshop WBA Walgreens Boots Alliance $40.53 / +0.62 (+1.55%) 07/22/22 Unusually active option classes on open July 22nd 06/17/22 Unusually active option classes on open June 17th 05/18/22 Unusually active option classes on open May 18th 04/26/22 Walgreen Boots call volume above normal and directionally bullish
Options	Pfizer call volume above normal and directionally bullish » 11:05 08/11/22 08/11 11:05 08/11/22 11:05 PFE Pfizer $48.72 / -1.21 (-2.42%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PFE Pfizer $48.72 / -1.21 (-2.42%) 08/08/22 Pfizer, Valneva initiate Phase 3 study of Lyme disease vaccine candidate VLA15 08/08/22 Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash 08/08/22 Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash 08/07/22 Myovant Sciences, Pfizer receive FDA approval of MYFEMBREE PFE Pfizer $48.72 / -1.21 (-2.42%) 08:34 Today Deutsche Bank Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank 08/09/22 Wells Fargo Global Blood Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo 08/08/22 Cantor Fitzgerald Global Blood downgraded to Neutral from Overweight at Cantor Fitzgerald 08/08/22 Oppenheimer Global Blood Therapeutics downgraded to Perform from Outperform at Oppenheimer PFE Pfizer $48.72 / -1.21 (-2.42%) 07/28/22 Pfizer raises FY22 adjusted EPS view to $6.30-$6.45 from $6.25-$6.45 07/28/22 Pfizer reports Q2 adjusted EPS $2.04, consensus $1.80 07/27/22 Notable companies reporting before tomorrow's open 07/27/22 Notable companies reporting before tomorrow's open PFE Pfizer $48.72 / -1.21 (-2.42%) 08/05/22 Pfizer in advanced talks to buy Global Blood for about $5B, WSJ reports 08/05/22 Pfizer in talks to buy Global Blood Therapeutics for about $5B, WSJ says 07/18/22 GSK CEO says split will help deal with 'perennial underperformance,' FT reports 06/28/22 FDA panel recommends omicron update for COVID vaccine boosters, CNBC says PFE Pfizer $48.72 / -1.21 (-2.42%) 08/08/22 What You Missed On Wall Street On Monday 08/08/22 What You Missed On Wall Street This Morning 08/08/22 Fly Intel: Pre-market Movers 08/05/22 What You Missed On Wall Street On Friday 09/10/22 ESMO Congress 2022 PFE Pfizer $48.72 / -1.21 (-2.42%) 07/28/22 Unusually active option classes on open July 28th 06/30/22 Early notable gainers among liquid option names on June 30th 05/20/22 Early notable gainers among liquid option names on May 20th 04/26/22 Unusually active option classes on open April 26th
General news	Treasury Action: yields are well off of early lows » 11:05 08/11/22 08/11 11:05 08/11/22 11:05 $ECON Economic Data / + Treasury Action: yields… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 02/11/22 Gundlach sees five interest rate raises in 2022 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
Recommendations	iStar tax-free combination to internalize Safehold management team, says Truist » 11:03 08/11/22 08/11 11:03 08/11/22 11:03 SAFE Safehold $42.97 / -0.47 (-1.08%) , STAR iStar $15.30 / -1.785 (-10.45%) Commenting on Safehold… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly SAFE STAR SAFE Safehold $42.97 / -0.47 (-1.08%) 06:38 Today Safehold, iStar enter strategic combination 07/20/22 Safehold closes transaction with Avanti Residential and $62.5M ground lease 06/15/22 Safehold increases quarterly stock dividend 4.12% to 17.7c per share 02/15/22 Safehold executes private sale of Caret Units at a valuation of $1.75B STAR iStar $15.30 / -1.785 (-10.45%) 06:38 Today Safehold, iStar enter strategic combination SAFE STAR SAFE Safehold $42.97 / -0.47 (-1.08%) 07/15/22 Morgan Stanley Safehold price target lowered to $85 from $100 at Morgan Stanley 06/28/22 B. Riley B. Riley says buy iStar into expected merger with Safehold 05/24/22 Raymond James iStar price target lowered to $21 from $33 at Raymond James 05/18/22 JPMorgan Safehold price target lowered to $52 from $66 at JPMorgan STAR iStar $15.30 / -1.785 (-10.45%) 06/28/22 B. Riley B. Riley says buy iStar into expected merger with Safehold 05/24/22 Raymond James iStar price target lowered to $21 from $33 at Raymond James 01/03/22 B. Riley iStar, Aspen Aerogels among B. Riley's top 25 stock picks for 2022 09/10/21 Fly Intel: Top five analyst initiations SAFE STAR SAFE Safehold $42.97 / -0.47 (-1.08%) 08/03/22 Safehold reports Q2 EPS 37c, consensus 40c 04/21/22 Safehold reports Q1 EPS 43c, consensus 42c 02/15/22 Safehold reports Q3 EPS 38c, consensus 41c STAR iStar $15.30 / -1.785 (-10.45%) 08/04/22 iStar reports Q2 adjusted EPS (42c), consensus (61c) 02/24/22 iStar reports Q4 adjusted EPS 87c, consensus (21c) 03 Mar 23 Sep STAR STAR iStar $15.30 / -1.785 (-10.45%) 04/23/22 Short Report: Stitch Fix bears gnawing on shares

Events

Earnings calls, analyst events, roadshows and more

Today at 11:30

4-Week Bill Auction Government Event
Today at 11:30

8-Week Bill Auction Government Event
RCMT
Today at 11:30

RCM Technologies - RCMT Conference Calls
MCHP
Today at 11:30

Semiconductors Industry Meetings
Today at 11:30

Retail & Consumer Goods Industry Meetings
CCAP
Today at 12:00

Crescent BDC - CCAP Conference Calls
FSM
Today at 12:00

Fortuna Silver Mines - FSM Conference Calls
MNTS
Today at 12:00

Momentus - MNTS Conference Calls
WDAY
Today at 12:00

Technology/Software Industry Meetings
EHC
Today at 12:30

Encompass Health - EHC Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	AYTU X AYTU Aytu BioPharma Spot Secondary Managers: Cantor Fitzgerald & Canaccord Priced at: $0.43 21.5M Shares BRBR X BRBR BellRing Brands Spot Secondary Managers: JPMorgan, Barclays, Citi, Goldman Sachs & Morgan Stanley Priced at: $23.50 14.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDNA X MDNA Medicenna Therapeutics Spot Secondary Managers: Guggenheim, Bloom Burton Securities Priced at: $1.50 13.333M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NUZE X NUZE NuZee Spot Secondary Managers: Maxim Priced at: $0.82 4.2M Shares PFLT X PFLT PennantPark Floating Rate Spot Secondary Managers: Morgan Stanley, Goldman Sachs, JPMorgan, Keefe Bruyette, RBC Capital & Truist Priced at: $12.40 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan, Jefferies Priced at: $215.00 3.49M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MIRM X MIRM Mirum Pharmaceuticals Spot Secondary Managers: JPMorgan, SVB Securities & Evercore ISI, Raymond James Priced at: $23.00 3.48M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TDW X TDW Tidewater Spot Secondary Managers: Morgan Stanley Priced at: $17.85 3.52M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	ATNX X ATNX Athenex Secondary Managers: SVB Securities Priced at: $.75 35.3M Shares CINC X CINC CinCor Pharma Secondary Managers: Goldman Sachs, Morgan Stanley, Jefferies & Piper Sandler Priced at: $30.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EVTC X EVTC Evertec Secondary Managers: JPMorgan Priced at: $32.00 6.26M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LXU X LXU LSB Industries Secondary Managers: Goldman Sachs & UBS, Deutsche Bank, Jefferies, Piper Sandler, RBC Capital, BNP Paribas, Stifel Priced at: $13.00 13.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SOVO X SOVO Sovos Brands Secondary Managers: JPMorgan & Goldman Sachs, BofA, Credit Suisse, Barclays, UBS, Cowen, Piper Sandler, Stifel, William Blair, Telsey Advisory, Drexel Hamilton, Loop Capital Priced at: $14.00 8.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRNA X VRNA Verona Pharma Secondary Managers: Jefferies, Piper Sandler & Truist Priced at: $10.50 12.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNL X BNL Broadstone Net Lease Spot Secondary Managers: Goldman Sachs, BMO Capital, JPMorgan & Truist Priced at: $21.35 13M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KIDS X KIDS OrthoPediatrics Spot Secondary Managers: Piper Sandler & Stifel Priced at: $55.00 750K Shares MAIN X MAIN Main Street Spot Secondary Managers: RBC Capital, UBS & Wells Fargo Priced at: $42.85 1.17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	TGL X TGL Treasure Global IPO Managers: EF Hutton Priced at: $4.00 2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	BIAF X BIAF Bioaffinity Technologies IPO Managers: WallachBeth $6.00-6.25 1.285M Shares
Wed	No deals
Thurs	FRZA X FRZA Forza X1 IPO Managers: ThinkEquity $5.00 3M Shares CERE X CERE Cerevel Therapeutics Secondary Managers: Morgan Stanley, Goldman Sachs, Jefferies & Evercore ISI, Loop Capital, Seibert Williams $41.42 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PTLO X PTLO Portillo's Secondary Managers: Jefferies & Morgan Stanley, BofA, Piper Sandler $28.44 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RANI X RANI Rani Therapeutics Secondary Managers: BofA, Cantor Fitzgerald & UBS, BTIG, H.C. Wainwright $11.11
Fri	No deals

View All Syndicate Announcements »

Citi 'incrementally cautious' on Kroger after Q1 call

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access